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Letters to the Editorentity. There are 4.6 million people in the
United States with heart failure today, and
550,000 new cases are being reported an-
nually by the American Heart Associa-
tion.5 Approximately 30% to 50% of pa-
tients with heart failure have a normal or
nearly normal left ventricular ejection frac-
tion.6 CHF is a leading cause of cardiac
morbidity and mortality from cardiovascu-
lar disease. Although left ventricular dia-
stolic dysfunction occurs in all patients
with systolic dysfunction and CHF, a third
of patients have CHF with isolated dia-
stolic dysfunction. In the general popula-
tion, the mortality among patients with di-
astolic heart failure is 4 times that among
persons without heart failure but half that
among patients with systolic heart failure.
It is widely known that many physicians
underappreciate diastolic function in heart
failure.
Reinterpreting the data in the context of
the discussion asks for other explanations.
In the present era of advancements in echo-
cardiography, diastolic dysfunction needs
to be taken into consideration, especially
when symptoms of congestive heart failure
are present. If that is the case in this study,
left ventricular dysfunction remains a pre-
dictor of outcome but with a change from
systolic to diastolic. Finally, I ask Davier-
wala and colleagues to take a second look
at their data in the light of this forgotten
predictor variable. I would appreciate their
feedback.
Jeffrey H. Shuhaiber, MD
University of Illinois at Chicago
Chicago, IL 60612
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Reply to the Editor:
Dr Shuhaiber correctly points out that left
ventricular (LV) diastolic dysfunction is
frequently superimposed on either normal
or reduced systolic function in patients un-
dergoing coronary artery bypass grafting.
The importance of diastolic dysfunction in
the development and progression of con-
gestive heart failure (CHF) has been illus-
trated previously1 and is highlighted by the
divergent trends in the prevalence of LV
systolic dysfunction and CHF in the series
on which we reported. Early echocardio-
graphic signs of impaired LV relaxation
include decreased early transmitral LV fill-
ing and greater dependence on atrial con-
traction.2 Pseudonormalization of LV fill-
ing is observed as LV stiffness and left
atrial pressures continue to increase, and
finally severe diastolic dysfunction is
marked by rapid early filling, extreme LV
stiffness, and elevated diastolic pressures.
This diastolic dysfunction has been shown
to predict outcomes in patients with CHF
independently of systolic function.3
Despite this, echocardiographic charac-
terization and quantitation of LV diastolic
dysfunction is not performed and recorded
for all patients undergoing coronary sur-
gery. This may be due in part to logistical
issues and in part to underappreciation of
its prognostic significance. Like systolic
function, diastolic function may also vary
significantly with time in patients with in-
termittent ischemia or a maturing myocar-
dial infarction.
Our institutional database, initiated in
1982 and now encompassing approxi-
mately 40,000 surgical patients, does not as
yet contain uniform data on diastolic func-
tion, nor does the much larger Society of
Thoracic Surgeons database. Thus, al-
though one may reasonably speculate that
the prevalence of diastolic dysfunction in
patients undergoing coronary artery bypass
grafting is increasing in parallel with other
risk factors, as we have reported in this
series, our data do not currently permit
evaluation of the independent effect of di-
astolic function on mortality and morbid-
ity. These measures of diastolic dysfunc-
e Journal of Thoracic and Cardiovascular Stion will have to obtained routinely for all
patients undergoing surgery and incorpo-
rated into institutional and regional data-
bases before we be able to determine
whether the decreasing influence of LV
systolic dysfunction on outcomes has un-
masked relatively more subtle predictors,
including CHF and left main stenosis as we
have reported or diastolic dysfunction as
Dr Shuhaiber suggests.
Piroze M. Davierwala, MD
Terrence M. Yau, MD, MSc
Division of Cardiovascular Surgery
Toronto General Hospital
Toronto, Ontario, Canada
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Extracapsular lymph node
involvement in esophageal cancer
and number of involved nodes
To the Editor:
We thank Dr DeMeester1 for his valuable
comments on our article “Extracapsular
Lymph Node Involvement Is a Negative
Prognostic Factor in T3 Adenocarcinoma
of the Distal Esophagus and Gastroesoph-
ageal Junction.”2 We fully agree with Dr
DeMeester1 that the number and character-
istics of lymph nodes are very important
determinants of survival in esophageal can-
cer, and we endorse his plea for taking the
number of involved nodes into account in
the TNM staging system of esophageal
cancer.
In his editorial,1 Dr DeMeester made
some points that we would like to clarify.
With regard to the survival in patients with-
out nodal involvement versus patients with
intracapsular nodal involvement, there was
no significant difference in survival. This
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Letters to the Editordoes not, however, mean that they had the
same survival. Applying a Cox regression
on these patients, we had a P value of .435
and a hazard ratio of 1.271 (95% confi-
dence interval 0.696-2.322), which means
that patients with intracapsular involved
lymph nodes have a 27% higher risk of
dying than did those with pN0 disease.
This hazard ratio is not extreme relative to
the hazard ratio of 3.37 in patients with
lymph node involvement. There were suf-
ficient patients at risk in each time interval:
33, 29, 24, 16, 15, and 12 for the pN0 group
and 60, 53, 36, 25, 17, and 14 for the
intracapsular group at 0, 1, 2, 3, 4, and 5
years, respectively.
The difference we found regarding the
mean and median number of involved
lymph nodes (3.68 and 3.0 for intracapsular
vs 7.96 and 6.0 for extracapsular) was
mainly caused by some extreme values in
the extracapsular group, which could indi-
cate that extracapsular involvement points
to more advanced disease. However, we
checked the interaction between lymph
node status and number of involved lymph
nodes by analysis of variance and ruled out
significant interaction between these vari-
ables, so both can be considered as inde-
pendent effects.
As to the subgroup of patients with ex-
actly one intracapsular versus one extra-
capsular involved lymph node, we agree
that a type II error is possible because of
the small group. The reason we included
this graph was merely to demonstrate the
effect of intracapsular versus extracapsular
involvement after having neutralized the
effect of number of positive lymph nodes.
Because of the small number of patients,
we couldn’t conclude that patients with one
intracapsular lymph node have a better sur-
vival than patients with no involved lymph
nodes. This graph merely shows the detri-
mental effect of extracapsular involvement
on survival.
Again, we would like to highlight the
importance of extracapsular involvement,
which seems far greater than the effect of
number of involved lymph nodes. As our
model indicates, the effect of extracapsular
involvement (237%) is much greater than
the cumulative effect of, for example, 12
positive nodes (12 8.6% 103.2%). For
this reason we believe that in addition to
the number of involved lymph nodes,
lymph node status (intracapsular vs extra-
capsular) should be routinely incorporated
1856 The Journal of Thoracic and Cardiovin every pathology report. If our results are
confirmed by other centers, then perhaps
extracapsular involvement should be incor-
porated in the TNM staging system as well,
unless indeed biologic and molecular bio-
logical markers, the Holy Grail of prognos-
tic indicators, are able to replace the actual
routine staging.
In conclusion, if you see one, ask your
pathologist to look at the capsula.
T. Lerut, MD, PhD
J. Moons, CNS
S. Fieuws, MSc
Department of Thoracic Surgery
Catholic University Leuven
UZ Gasthuisberg
Herestraat 49
3000 Leuven, Belgium
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Skeletonized bilateral internal
thoracic arteries in patients with
diabetes: Additional advantages and
concerns
To the Editor:
The article by Peterson and colleagues1
published in the November 2003 issue of
the Journal is clearly an important study
demonstrating the beneficial impact of us-
ing skeletonized bilateral internal thoracic
artery (ITA) grafts on the incidence of ster-
nal wound infection in patients with diabe-
tes. In terms of morbidity, sternal dehis-
cence as a consequence of sternal
devascularization is the most worrying po-
tential complication of bilateral ITA grafts,
particularly in patients with diabetes. Pa-
tients with diabetes are those with poten-
tially most to gain from bilateral ITA
grafts, because they often have more se-
vere, diffuse, and distal disease. Appropri-
ate patient selection and modification of the
technique for harvesting the ITA can sig-
nificantly reduce the risk of impaired
ascular Surgery ● June 2004wound healing in these patients. Harvest-
ing the ITA with the traditional pedicled
technique also involves harvest of sur-
rounding parietal pleura, venae comitantes,
muscle, and fascia, leaving a completely
denuded and devascularized strip of chest
wall. Harvesting only the ITA itself (“skel-
etonizing” technique) preserves intercostal
collateral vessels and some sternal blood
supply. Not only does the skeletonization
technique result in superior sternal blood
flow preservation2 and reduce risk of
wound healing in all patients3 and those
with diabetes in particular,4,5 it also offers
several additional advantages. These in-
clude aiding judgment of graft length, pro-
vision of extra length (an important consid-
eration if the ITA is to be used for more
than a single graft, as a sequential graft),
allowing thorough visual inspection to
identify spastic or damaged areas that
could otherwise be obscured by perivascu-
lar fat, facilitating sequential anastomoses
and composite arterial grafting (because
the venae comitantes, perivascular fat, and
areolar tissue do not obscure the anastomo-
sis), and minimizing the risks of kinks or
twists in the conduit.
There are, however, several points of
caution to be emphasized with the skel-
etonization technique. It is technically
more demanding than pedicle harvesting,
and careful and meticulous dissection is
required. Skeletonization takes longer than
does the pedicle technique and has a defi-
nite learning curve. Small arterial branches
can be inadvertently avulsed by excessive
downward retraction, resulting in injury to
the artery and compromising long-term pa-
tency. Finally, skeletonization probably in-
duces a greater degree of spasm.
Perhaps what is missing from this par-
ticular study is the incidence of ITA injury
sustained during skeletonization and the
fate of any injured ITAs. Also, it would be
interesting to know about the authors’ ex-
perience of ITA spasm resulting from skel-
etonization and any measures they took to
deal with it.
Shahzad G. Raja, MRCS
Department of Cardiac Surgery
Alder Hey Children’s Hospital
Liverpool, United Kingdom
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